2,4-Diamino-5-benzylpyrimidines, especially for the treatment of microbial infections, pharmaceutical compositions containing these compounds and processes for preparing these compounds
申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0006987A1
公开(公告)日:1980-01-23
Pharmaceutical compositions containing 2,4-diamino-5-(3. 5-dialkyl-4-hydroxybenzyl) pyrimidines wherein the alkyl groups contain from 2 to 4 carbon atoms are useful in the treatment of bacterial infections. The first medical use of such compounds, novel chemical compounds wherein the alkyl groups are propyl or butyl, except the di-i-propyl compound, a process for preparing the novel compounds and chemical intermediates used in their preparation are also disclosed.
含有 2,4-二氨基-5-(3. 5-二烷基-4-羟基苄基)嘧啶(其中烷基含有 2 至 4 个碳原子)的药物组合物可用于治疗细菌感染。此外,还公开了此类化合物的第一种医学用途、烷基为丙基或丁基的新型化合物(二丙基化合物除外)、制备新型化合物的工艺以及用于制备这些化合物的化学中间体。